New York, USA, May 12, 2026 (GLOBE NEWSWIRE) -- Sepsis Clinical Trial Pipeline Appears Robust With 25+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight The sepsis ...

A promising new drug to combat sepsis has been developed by researchers at The Australian National University (ANU), potentially saving millions of lives each year. ANU Professor Christopher Parish ...

The body's extreme response to infection, a condition called sepsis, kills 11 million people every year. This is because to survive a serious infection it is not enough to get rid of the infectious ...

A research team has discovered a previously unknown mechanism by which the immune system fights bacterial infections. The scientists found that a specific protein, the chloride channel PACC1, is ...

The immune system typically can ramp up the body's defenses to clear out an invading threat without issue. Glitches can happen, however, with sepsis occurring when the mustered army of cells also ...

Researchers discovered that patient survival from sepsis is associated with higher platelet counts, and identified two currently available drugs that protect these blood cells and improve survival in ...

A groundbreaking clinical trial conducted at the Austin Hospital in Melbourne has introduced a new ray of hope for the often-fatal diagnosis of sepsis. Sepsis “is the biggest killer in intensive care ...

Drotrecogin alfa (activated), a serine protease with anti-inflammatory and anti-thrombotic properties was approved in 2001 in the United States for use against severe sepsis in adults with multiple ...

Research led by the IGC reveals how these drugs limit inflammation, positioning them as potential treatments for sepsis. The study, published in eLife, reveals that this class of drugs used in cancer ...